In fact, despite a slew of references to the glory days of the late '90s and talk of a stock market bubble, this year's stock surge is nothing like 1999, a go-go period on Wall Street when the market was ruled by an oligarchy of large tech stocks like Microsoft, Cisco Systems and Oracle.
Indeed, this year's rally isn't a Nifty-Fifty-type advance, where a few "brand name" stocks do most of the heavy lifting and power the performance. Nope, this year's rally has been driven by nearly every single stock that trades in the benchmark Standard & Poor's 500-stock index.
BULL MARKET: S&P 500 level a bellwether?
Not only does the S&P 500's 26.6% year-to-date put it on track for its best year since 1998, it's also far better than the 19.5% return in 1999.
Top 10 Healthcare Technology Companies To Watch For 2015: AVG Technologies NV (AVG)
AVG Technologies N.V. (AVG), incorporated on March 3, 2011, provides software and online services. The Company is primarily engaged in the development and sale of Internet security software and online service solutions branded under the AVG name. The Company�� solutions include software and online services, include security, personal computer (PC) management, online backup and other products. As of December 31, 2011, the Company had approximately 15 million subscription users. AVG�� portfolio consists of Anti-Virus suite, Internet Security suite, Premium Security suite, AVG Mobilation, AVG Threatlabs, Family Safety, TuneUp Utilities and PC Tuneup, LiveKive and MultiMi. On January 4, 2011, the Company acquired DroidSecurity Ltd. On March 3, 2011, the Company established AVG Holding Cooperatief U.A. On May 18, 2011, the Company acquired iMedix Web Technologies Ltd. In August 2011, it acquired TuneUp Software GmbH. On August 19, 2011, AVG Technologies GER GmbH acquired TuneUp Software GmbH. On October 31, 2011, AVG Technologies Holdings B.V. acquired AVG Distribution Switzerland AG. In November 2011, the Company acquired Bsecure Solutions, Inc. On January 13, 2012, AVG Technologies USA, Inc. acquired OpenInstall, Inc. In May 2013, AVG Technologies NV acquired online privacy organisation PrivacyChoice.
The Company�� products include AVG Internet Security, AVG Anti-Virus, AVG Email Server Edition, AVG File Server Edition, AVG Linux Server Edition, AVG Rescue CD and AVG Remote Administration. The Company�� subsidiaries include AVG Technologies USA Inc., AVG Technologies CZ, s.r.o., AVG Technologies UK Ltd, AVG Exploit Prevention Labs, Inc., AVG Technologies GER, GmbH, AVG Technologies FRA SAS, AVG Technologies HK, Limited, AVG (Beijing) Internet Security Technologies Company Limited, AVG Mobile Technologies Ltd, AVG Netherlands B.V., AVG Ecommerce CY Ltd, AVG Technologies Holding B.V., TuneUp Software GmbH, TuneUp Distribution GmbH, TuneUp Corporation and AVG Distribution Switzerland AG! .
The Company competes with Microsoft, Google, Apple, Qihoo, Tencent, Facebook, UniBlue, Symantec, Trend Micro, Avast!, Avira, Symantec, Carbonite, Dropbox, Intel Corporation, Trend Micro, Eset, Kaspersky Labs, Panda Software, Sophos, Rising, Kingsoft, Check Point and F-Secure.
Advisors' Opinion:- [By Seth Jayson]
AVG Technologies (NYSE: AVG ) reported earnings on April 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), AVG Technologies beat expectations on revenues and crushed expectations on earnings per share. - [By Igor Novgorodtsev]
InterActiveCorp (IACI) bought Ask.com for $1.85 billion in 2005. The new Perion will be worth only about 40% of that. After the merger, Perion will leapfrog its much larger rivals: Babylon and AVG (AVG). Finally, Perion should be able to increase its operating margins as it can spread its SG&A costs over a much larger base (Conduit EBITDA margin is 32% vs. Perion's 23%). Perion will keep its senior management team intact: Josef Mandelbaum will remain its CEO and Yacov Kaufman its CFO. Perion has successfully orchestrated a roll-up acquisitions of privately-held Sweetpacks and Smilebox, so I have high confidence that they know how to integrate a new business.
- [By MONEYMORNING]
For instance, in the March 15 Private Briefing report, "Double Your Money With this Cyber-Hacking of America Stock," we recommended AVG Technologies NV (NYSE: AVG), an Amsterdam-based cybersecurity whose shares we believed were good for a 100% gain in a year.
Hot Tech Stocks For 2014: National Instruments Corporation(NATI)
National Instruments Corporation designs, manufactures, and sells measurement and automation products to create virtual instrumentation systems for general, commercial, industrial, and scientific applications worldwide. The company sells or licenses application software and modular hardware that combines with industry-standard computers, networks, and third party devices to create measurement, automation, and embedded systems. Its system design software products include LabVIEW to design custom virtual instruments for scientists and engineers and provide data analysis, visualization, and sharing features; LabVIEW Real-Time and LabVIEW FPGA, which are modular software add-ons enabling users to configure their application programs and to build custom hardware devices for measurement or control protocols. The company also offers LabWindows/CVI programming environment for creating test and control applications; and Measurement Studio, which consists of measurement and automati on add-on libraries and additional tools for programmers. Its application software products include NI TestStand, a test management environment; NI VeriStand, a ready-to-use software environment; NI DIAdem that offers configuration-based technical data management, analysis, and report generation tools; and NI Multisim, which offers circuit design technology. In addition, the company provides hardware products and related driver software comprising data acquisition hardware/driver software, PXI modular instrumentation platform, modular instruments, machine vision/image acquisition, motion control, NI RIO hardware platform, industrial communications interfaces, GPIB interfaces/driver software, and VXI controllers/driver software. Further, it offers system configuration and deployment, calibration, warranty and repair, and customer training services, as well as software maintenance and technical support. National Instruments Corporation was founded in 1976 and is headquartered in Austin, Texas.
Advisors' Opinion:- [By Brian Pacampara]
What: Shares of scientific tools manufacturer National Instruments (NASDAQ: NATI ) sank 13% today after its quarterly results and guidance missed Wall Street expectations. �
- [By Eric Volkman]
National Instruments (NASDAQ: NATI ) has elected to maintain its dividend. The company declared a distribution of $0.14 per share, to be paid on Sept. 3 to shareholders of record as of Aug. 12. That amount matches each of the company's previous six distributions, the most recent of which was paid at the beginning of June. Before that, National Instruments handed out $0.10 per share.
Hot Tech Stocks For 2014: Rexahn Pharmaceuticals Inc (RNN)
Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company�� pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. In addition, the Company has two renal cell carcinoma (CNS) candidates, Serdaxin, CNS Disorders drug for depression and neurodegenerative diseases and Zoraxel, which is a erectile dysfunction (ED) and sexual dysfunction drug that are in clinical stages and the Company is are exploring options for further development . The Company�� drug candidate, Archexin is an anticancer Akt inhibitor.
Archexin
Archexin is potent inhibitor of the Akt protein kinase (Akt) in cancer cells. Archexin has FDA orphan drug designations for five cancers (RCC, glioblastoma, and cancers of the ovary, stomach and pancreas). Multiple indications for other solid tumors can also be pursued. Archexin inhibit both activated and inactivated forms of Akt, and to reverse the drug resistance observed with the protein kinase inhibitors. Archexin is an antisense oligonucleotide (ASO) compound that is complementary to Akt mRNA, and selective for inhibiting mRNA expression and production of Akt protein. As of December 31, 2011, Archexin was in Phase II clinical trials for the treatment of pancreatic cancer with enrollment completed in September, 2011.
Serdaxin
Serdaxin is an extended release formulation of clavulanic acid, which is an ingredient present in antibiotics approved by the FDA. The Company had been developing Serdaxin for the treatment of depression and neurodegenerative disorders. From January to September, 2011, the Company conducted a randomized, double-blind, placebo-controlled study compared two doses of Serdaxin, 0.5 milligram and 5 milligram, to placebo over an eight-week treatment period for major depressive disorder (MDD) patients. As of Dec! ember 31, 2011, the Company had not made a determination of Serdaxin�� future paths or resource allocations to further develop Serdaxin to treat MDD.
Zoraxel
Zoraxel is an orally administered, on-demand tablet to treat sexual dysfunction. Zoraxel is a dual enhancer of neurotransmitters in the brain that play a key role in sexual activity phases of motivation and arousal, erection and release, and may be the ED drug to affect all three of these phases of sexual activity. As of December 31, 2011, the Company was evaluating how to proceed with the Phase IIb study of Zoraxel.
The Company�� Pre-clinical Pipeline Drug Candidates includes RX-1792, which is a small molecule anticancer EGFR inhibitor; RX-5902, which is a small molecule anticancer ribonucleic acid (RNA) helicase regulator; RX-3117, which is a Small molecule anticancer deoxyribonucleic acid (DNA) synthesis Inhibitor; RX-8243, which is a small molecule anticancer aurora kinase inhibitor; RX-0201-Nano, which is a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, which is an nanoliposomal anticancer HIF-1 alpha inhibitor and RX-21101, which is a nano-polymer Anticancer.
Advisors' Opinion:- [By James E. Brumley]
At first glance, Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) doesn't look like anything particularly trade-worthy. The stock's now where it was in late October, and where it was in late September, and even where it was in late June. In other words, though RNN has been much higher and much lower than its current price of $0.46 over the course of the past several months, it doesn't look like it's going anywhere - on a net basis - anytime.
- [By James E. Brumley]
With just a quick glance at a chart of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), it would be easy to conclude it's nothing but a volatile mess. When you take a step back and look at a long-term weekly chart of RNN, however, it starts to become clear that this small cap biopharma name is on the verge of a monster-sized breakout. First things first, however.
- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's just starting to move into breakout territory is Rexahn Pharmaceuticals (RNN), which is engaged in the development of novel treatments for cancer to patients. This stock has been on fire so far in 2013, with shares up sharply by 62%.
If you take a look at the chart for Rexahn Pharmaceuticals, you'll notice that this stock has been uptrending strong for the last month, with shares moving higher from its low of 36 cents per share to its intraday high of 53 cents per share. During that uptrend, shares of RNN have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of RNN into breakout territory above some near-term overhead resistance levels at 49 cents to 50 cents per share. It's worth noting that volume today is tracking in extremely strong with over 3 million shares traded, versus its three-month average action of 1.22 million shares.
Traders should now look for long-biased trades in RNN if it manages to break out above Thursday's intraday high of 53 cents per share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.22 million shares. If that breakout hits soon, then RNN will set up to re-test or possibly take out its next major overhead resistance levels at 64 cents to its 52-week high at 66 cents per share. Any high-volume move above 66 cents to 67 cents per share could then send RNN towards its next major overhead resistance levels at 81 cents per share.
Traders can look to buy RNN off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at 47 cents per share. One can also buy RNN off strength once it clears 53 cents per share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Hot Tech Stocks For 2014: Actuate Corp (BIRT)
Actuate Corporation (Actuate), incorporated in November 1993, provides software and services to develop and deploy custom Business Intelligence and information applications. Actuate offers ActuateOne to develop and deploy Business Intelligence and Reporting Tools (BIRT)-based custom Business Intelligence and information applications focusing on browsers and mobile devices that deliver content hosted in cloud, software-as-a-service (SaaS) and on premises deployments. Its products and services are used by its customers to develop and deploy applications across a range of business functions, including financial management, sales management, account management, and customer self-service. Xenos solutions, based on Xenos Enterprise Server, loads, transforms and presents high volumes of data and documents across multiple channels. Actuate�� BIRT Spreadsheet products are Excel-based. In February 2014, Actuate Corporation announced the acquisition of legodo ag.
ActuateOne-Business Intelligence, Analytics and Reporting
Actuate offers a range of BIRT-based Business Intelligence (BI), analytics and reporting features within the integrated ActuateOne platform, providing 64-bit, in-memory analytics, user configurable dashboards, ad-hoc query, interactive mobile and Web content, brochure-quality reporting, and spreadsheet analysis. ActuateOne provides a platform upon which Global 9000 and packaged application software vendors develop and deploy BI and information applications. Such applications retrieve business information from databases, as well as print streams and deliver it as dashboards, interactive Web pages, spreadsheets, mobile content and analytic cubes to customers, partners and employees worldwide.
Xenos Enterprise Server Framework
Xenos Enterprise Server (ES) is an application that captures, identifies, routes, stores and retrieves structured and unstructured documents and data. Xenos ES supports the processing, extraction, transformation, repurposi! ng and personalization of structured and unstructured data in both legacy and SOA environments. Xenos ES distributes documents across multiple channels, such as Web, mobile and tablet devices in addition to providing interactivity and document analytics through its integration with ActuateOne.
Performance Analytics
Actuate BIRT Performance Analytics provides interactive dashboards, analytics, and scorecards. With Web interface, users across the enterprise can monitor operations, identify and analyze performance issues and enact initiatives.
BIRT Spreadsheet
Actuate�� BIRT Spreadsheet products deliver Excel-like reporting, formatting and calculation functionality within Java applications. Actuate BIRT Spreadsheet products can also leverage all the Actuate deployment options-embedded in applications or deployed cloud or on-premise enterprise environments.
The Company competes with Information Builders, Qlik Tech, Pentaho, Jaspersoft, MicroStrategy, IBM, Microsoft, Oracle and SAP.
Advisors' Opinion:- [By John Udovich]
Yesterday, small cap business intelligence stock MicroStrategy Incorporated (NASDAQ: MSTR) surged 18.44%�after reporting better-than-expected third quarter earnings ��meaning it might be a good idea to take a closer look at it�along with�small cap peers Actuate Corporation (NASDAQ: BIRT) and Qlik Technologies Inc (NASDAQ: QLIK) to see what they might offer small cap investors. After all, everyone is being inundated with huge amounts of data from multiple sources, but its the following small cap stocks that provide software platforms to help customers try to make sense of it all:�
- [By Roberto Pedone]
Actuate (BIRT) provides software solutions and services to corporate and government customers worldwide. This stock closed up 1.7% to $4.54 in Tuesday's trading session.
Tuesday's Range: $4.43-$4.57
52-Week Range: $3.41-$8.23
Tuesday's Volume: 213,000
Three-Month Average Volume: 319,262From a technical perspective, BIRT trended modestly higher here back above its 50-day moving average of $4.51 with lighter-than-average volume. This move to the upside on Tuesday is starting to push shares of BIRT within range of triggering a major breakout trade. That trade will hit trigger if BIRT manages to take out some key overhead resistance levels at $4.60 to $4.75 and then above more resistance at $4.85 with high volume.
Traders should now look for long-biased trades in BIRT as long as it's trending above some key near-term support levels at $4.30 to $4.25 and then once it sustains a move or close above those breakout levels with volume that hits near or above 319,262 shares. If that breakout starts soon, then BIRT will set up to re-fill some of its previous gap-down-day zone from May that started near $6.
Hot Tech Stocks For 2014: ADT Corp (ADT)
The ADT Corporation (ADT), incorporated on January 18, 2012, is a provider of electronic security, interactive home and business automation, and monitoring services for residences and small businesses in the United States and Canada. The Company�� products and services include ADT Pulse interactive home and business solutions, and home health services. ADT provides business security intrusion detection, which protect the business from burglary, robbery and intruders. Its electronic access control limits unauthorized entry and employee access to the business, as well as complete access. Effective August 2, 2013, The ADT Corp acquired Devcon Security Services Corp, a provider of security protection services, from Devcon International Corp. In November 2013, Kastle Systems International announced that it had acquired Mutual Central Alarm Services and Stat-Land Security Systems from ADT Corporation.
The Company's video surveillance views events in multiple areas of facility, which has control over loss and oversees business. On October 1, 2012, the Company completed the acquisition of Absolute Security.
Advisors' Opinion:- [By Jim Powell]
As my top pick for the coming year, I like the long-term outlook for ADT Corporation (ADT), a major home security company that was spun-off from Tyco International last year.
- [By John Divine]
Another victim of a weak earnings call, shares of security company ADT (NYSE: ADT ) lost 6.9% after posting profits that rose just 2%. Despite adding more than 300,000 new customers, revenue failed to meet expectations, coming in at $821 million -- analysts were calling for about $824 million. While today's slide was extreme, the company isn't exactly in major trouble. It just seems to be in a phase of slow, steady growth.�
- [By Jonas Elmerraji]
We're seeing the exact same setup in shares of security monitoring firm ADT (ADT) right now. The big difference is that ADT has shown investors some miserable relative strength in 2013. Unlike Corning, this stock has actually managed to lose 12% during a double-digit rally in the rest of the market. That weakness coming into the fourth quarter makes ADT look more likely to follow through with a breakdown.
In ADT's chart, the key support level comes in at $39. If shares can't hold that price level, it's time to hit the sell button. Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Triangles and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.
That support level at $39 is a price at which there had been an excess of demand of shares; in other words, it's a place at which buyers were more eager to step in and buy shares at a lower price than sellers were to sell. That's what makes a breakdown below $39 so significant; the move would indicate that sellers are finally strong enough to absorb all of the excess demand above that price level. Wait for that trigger before you sell.
Lower highs in momentum add some extra confidence to the bear bias in ADT this fall.
Hot Tech Stocks For 2014: Aetrium Incorporated(ATRM)
Aetrium Incorporated designs, manufactures, and markets electromechanical equipment for the semiconductor industry to handle and test integrated circuits (ICs). The company provides test handler products, which incorporates thermal conditioning, contacting, and automated handling technologies to provide automated handling of ICs during production of test cycles; change kits to adapt test handlers to various IC package configurations or to upgrade installed equipment; and gravity feed test handlers. It also offers reliability test equipment, which provides structural performance data to aid in the evaluation and improvement of IC designs and manufacturing processes. The company sells its products to semiconductor manufacturers, and their assembly and test subcontractors through direct salespeople, independent sales representatives, and distributors in the United States, the United Kingdom, France, Germany, Italy, Korea, Japan, Taiwan, China, Thailand, Malaysia, Singapore, a nd the Philippines. Aetrium Incorporated was founded in 1982 and is based in North St. Paul, Minnesota.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the Move: Aetrium Inc. (NASDAQ: ATRM) is up 156.2% at $12.40 following a positive report based on a recent management change and new products. Mediabistro Inc. (NASDAQ: MBIS) is down 17.4% at $3.41 as the stock gives back some of the 87% gain it scored yesterday. J.C. Penney Co. Inc. (NYSE: JCP) is up 7.7% at $10.08 on momentum from an insider stock purchase earlier this week.
No comments:
Post a Comment